Andy Chen
Stock Analyst at Wolfe Research
(0.62)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BBIO BridgeBio Pharma | Initiates Coverage On: Outperform | 49 | 43.88 | 11.67% | 1 | Jun 17, 2025 | |
SRPT Sarepta Therapeutics | Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Jun 17, 2025 | |
RNA Avidity Biosciences | Initiates Coverage On: Outperform | 55 | 30.23 | 81.94% | 1 | Jun 17, 2025 | |
BPMC Blueprint Medicines | Downgrades: Peer Perform | n/a | n/a | n/a | 1 | Jun 3, 2025 | |
MLTX MoonLake | Upgrades: Outperform | 61 | 45.87 | 32.98% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 21 | 9.77 | 114.94% | 2 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 20 | n/a | n/a | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 49 | 22.61 | 116.72% | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 19 | 9.97 | 90.57% | 1 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 2 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 697 | 572.19 | 21.81% | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 3 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 65 | 47.27 | 37.51% | 2 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Peer Perform | n/a | n/a | n/a | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 1 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Peer Perform | n/a | n/a | n/a | 1 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 17 | 11.68 | 45.55% | 1 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 42 | 105.86 | -60.32% | 1 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Buy | 60 | n/a | n/a | 1 | Aug 8, 2023 |